Human three-dimensional engineered neural tissue reveals cellular and molecular events following cytomegalovirus infection

Biomaterials

Volumn 53, Issue , 2015, Pages 296-308

  Cosset, Érika ^a,b   Martinez, Yannick ^b,c   Preynat Seauve, Olivier ^a   Lobrinus, Johannes Alexander ^a   Tapparel, Caroline ^a   Cordey, Samuel ^a   Peterson, Hedi ^b   Petty, Tom J ^b   Colaianna, Marilena ^b   Tieng, Vannary ^b   Tirefort, Diderik ^a,b   Dinnyes, Andras ^c,d   Dubois Dauphin, Michel ^b   Kaiser, Laurent ^a   Krause, Karl Heinz ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c BIOTALENTUM LTD   (Hungary)

^d SZENT ISTVÁN UNIVERSITY   (Hungary)

Author keywords

Infection; Nerve tissue engineering; Neural cell; Stem cell

Indexed keywords

BRAIN; CELL ENGINEERING; CYTOLOGY; HISTOLOGY; PHYSIOLOGICAL MODELS; STEM CELLS; TISSUE ENGINEERING;

CENTRAL NERVOUS SYSTEMS; GROWTH AND DEVELOPMENT; HUMAN CYTOMEGALOVIRUS; IMMUNOHISTOCHEMICAL ANALYSIS; INFECTION; NERVE TISSUE ENGINEERING; NEURAL CELLS; TRANSCRIPTOME ANALYSIS;

TISSUE;

BETA TUBULIN; BIOLOGICAL MARKER; CYCLINE; DOUBLECORTIN; NESTIN; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX1; VIMENTIN;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOMEGALOVIRUS INFECTION; DENTATE GYRUS; FETUS; GENE EXPRESSION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIPID METABOLISM; MITOSIS; NERVOUS TISSUE; PRIORITY JOURNAL; STEM CELL NICHE; THREE DIMENSIONAL IMAGING; TISSUE ENGINEERING; VIRUS REPLICATION; CELL LINE; EMBRYOLOGY; METABOLISM; NERVOUS SYSTEM; VIROLOGY;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

CELL LINE; CYTOMEGALOVIRUS INFECTIONS; HUMANS; NERVOUS SYSTEM; TISSUE ENGINEERING;

EID: 84927942085     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.02.094     Document Type: Article

References (49)

1. Demmler G.J. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991, 13:315-329.
2. Ornoy A., Diav-Citrin O. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol 2006, 21:399-409.
3. Cheeran M.C., Lokensgard J.R., Schleiss M.R. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev 2009, 22:99-126.
4. Revello M.G., Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002, 15:680-715.
5. Chang W.L., Tarantal A.F., Zhou S.S., Borowsky A.D., Barry P.A. Arecombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques. JVirol 2002, 76:9493-9504.
6. McGregor A., Choi K.Y. Cytomegalovirus antivirals and development of improved animal models. Expert Opin Drug Metab Toxicol 2011, 7:1245-1265.
7. Tsutsui Y., Kosugi I., Kawasaki H., Arai Y., Han G.P., Li L., et al. Roles of neural stem progenitor cells in cytomegalovirus infection of the brain in mouse models. Pathol Int 2008, 58:257-267.
8. Landolfo S., Gariglio M., Gribaudo G., Lembo D. The human cytomegalovirus. Pharmacol Ther 2003 Jun, 98(3):269-297.
9. Davison A.J., Bhella D. Comparative genome and virion structure. Human herpesviruses: biology, therapy, and immunoprophylaxis 2007, Cambridge University Press, Cambridge, Chapter 14. A. Arvin, G. Campadelli-Fiume, E. Mocarski, P.S. Moore, B. Roizman, R. Whitley (Eds.).
10. Tsutsui Y., Kosugi I., Kawasaki H. Neuropathogenesis in cytomegalovirus infection: indication of the mechanisms using mouse models. Rev Med Virol 2005, 15(5):327-345.
11. Matsukage S., Kosugi I., Kawasaski H., Miura K., Kitani H., Tsutsui Y. Mouse embryonic stem cells are not susceptible to cytomegalovirus but acquire susceptibility during differentiation. Birth Defects Res A Clin Mol Teratol 2006, 76:115-125.
12. Kawasaki H., Kosugi I., Arai Y., Iwashita T., Tsutsui Y. Mouse embryonic stem cells inhibit murine cytomegalovirus infection through a multi-step process. PLoS One 2011, 6:e17492.
13. Cheeran M.C., Hu S., Ni H.T., Sheng W., Palmquist J.M., Peterson P.K., et al. Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways. JNeurosci Res 2005, 82(6):839-850.
14. Luo M.H., Schwartz P.H., Fortunato E.A. Neonatal neural progenitor cells and their neuronal and glial cell derivatives are fully permissive for human cytomegalovirus infection. JVirol 2008, 82:9994-10007.
15. Jault F.M., Jault J.M., Ruchti F., Fortunato E.A., Clark C., Corbeil J., et al. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. JVirol 1995, 69:6697-6704.
16. Lu M., Shenk T. Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. JVirol 1996, 70:8850-8857.
17. Dittmer D., Mocarski E.S. Human cytomegalovirus infection inhibits G1/S transition. JVirol 1997, 71:1629-1634.
18. Salvant B.S., Fortunato E.A., Spector D.H. Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. JVirol 1998, 72:3729-3741.
19. Odeberg J., Wolmer N., Falci S., Westgren M., Seiger A., Söderberg-Nauclér C. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. JVirol 2006, 80(18):8929-8939.
20. Odeberg J., Wolmer N., Falci S., Westgren M., Sundtröm E., Seiger A., et al. Late human cytomegalovirus (HCMV) proteins inhibit differentiation of human neural precursor cells into astrocytes. JNeurosci Res 2007, 85(3):583-593.
21. D'Aiuto L., Di Maio R., Heath B., Raimondi G., Milosevic J., Watson A.M., et al. Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells. PLoS One 2012, 7(11).
22. Lokensgard J.R., Cheeran M.C., Gekker G., Hu S., Chao C.C., Peterson P.K. Human cytomegalovirus replication and modulation of apoptosis in astrocytes. JHum Virol 1999, 2(2):91-101.
23. Luo M.H., Hannemann H., Kulkarni A.S., Schwartz P.H., O'Dowd J.M., Fortunato E.A. Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells. JVirol 2010, 84:3528-3541.
24. McCarthy M., Auger D., Whittemore S.R. Human cytomegalovirus causes productive infection and neuronal injury in differentiating fetal human central nervous system neuroepithelial precursor cells. JHum Virol 2000, 3:215-228.
25. Belzile J.P., Stark T.J., Yeo G.W., Spector D.H. Human cytomegalovirus infection of human embryonic stem cell-derived primitive neural stem cells is restricted at several steps but leads to the persistence of viral DNA. JVirol 2014, 88(8):4021-4039.
26. Pan X., Li X.J., Liu X.J., Yuan H., Li J.F., Duan Y.L., et al. Later passages of neural progenitor cells from neonatal brain are more permissive for human cytomegalovirus infection. JVirol 2013, 87(20):10968-10979.
27. Zhu H., Cong J.P., Shenk T. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc Natl Acad Sci U S A 1997, 94(25):13985-13990.
28. Zhu H., Cong J.P., Mamtora G., Gingeras T., Shenk T. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci U S A 1998, 95(24):14470-14475.
29. Challacombe J.F., Rechtsteiner A., Gottardo R., Rocha L.M., Browne E.P., Shenk T., et al. Evaluation of the host transcriptional response to human cytomegalovirus infection. Physiol Genomics 2004, 18(1):51-62.
30. Browne E.P., Wing B., Coleman D., Shenk T. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. JVirol 2001, 75(24):12319-12330.
31. Navarro L., Mowen K., Rodems S., Weaver B., Reich N., Spector D., et al. Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol Cell Biol 1998, 18(7):3796-3802.
32. Boyle K.A., Pietropaolo R.L., Compton T. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol Cell Biol 1999, 19(5):3607-3613.
33. Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008, 8(7):559-568.
34. Preynat-Seauve O., Suter D.M., Tirefort D., Turchi L., Virolle T., Chneiweiss H., et al. Development of human nervous tissue upon differentiation of embryonic stem cells in three dimensional culture. Stem Cells 2009.
35. Nayernia Z., Turchi L., Cosset E., Peterson H., Dutoit V., Dietrich P.Y., et al. The relationship between brain tumor cell invasion of engineered neural tissues and invivo features of glioblastoma. Biomaterials 2013, 34(33):8279-8290.
36. Karber G. 50% end-point calculation. Arch Exp Pathol Pharmak 1931, 480-483.
37. Johnson W.E., Li C., Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8(1):118-127.
38. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5(10):R80.
39. Reimand J., Kull M., Peterson H., Hansen J., Vilo J. g:Profiler-a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res 2007, 35(Web Server issue):W193-W200.
40. Reimand J., Arak T., Vilo J. g:Profiler-a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res 2011, 39(Web Server issue):W307-W315. 10.1093/nar/gkr378.
41. Burgos J.S., Ramirez C., Guzman-Sanchez F., Alfaro J.M., Sastre I., Valdivieso F. Hematogenous vertical transmission of herpes simplex virus type 1 in mice. JVirol 2006, 80(6):2823-2831.
42. Perlman J.M., Argyle C. Lethal cytomegalovirus infection in preterm infants: clinical, radiological, and neuropathological findings. Ann Neurol 1992, 31(1):64-68.
43. Tsutsui Y. Effects of cytomegalovirus infection on embryogenesis and brain development. Congenit Anom (Kyoto) 2009, 49(2):47-55.
44. Tsutsui Y., Kawasaki H., Kosugi I. Reactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures. JVirol 2002, 76(14):7247-7254.
45. Shinmura Y., Kosugi I., Aiba-Masago S., Baba S., Yong L.R., Tsutsui Y. Disordered migration and loss of virus-infected neuronal cells in developing mouse brains infected with murine cytomegalovirus. Acta Neuropathol 1997, 93(6):551-557.
46. Shinmura Y., Aiba-Masago S., Kosugi I., Li R.Y., Baba S., Tsutsui Y. Differential expression of the immediate-early and early antigens in neuronal and glial cells of developing mouse brains infected with murine cytomegalovirus. Am J Pathol 1997, 151(5):1331-1340.
47. Gabrielli L., Bonasoni M.P., Santini D., Piccirilli G., Chiereghin A., Petrisli E., et al. Congenital cytomegalovirus infection: patterns of fetal brain damage. Clin Microbiol Infect 2012, 18(10).
48. van Den Pol A.N., Mocarski E., Saederup N., Vieira J., Meier T.J. Cytomegalovirus cell tropism, replication, and gene transfer in brain. JNeurosci 1999, 19(24):10948-10965.
49. Lois C., Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A 1993, 90(5):2074-2077.